Literature DB >> 3622606

Evidence for dopaminergic involvement in tolerance to the discriminative stimulus properties of cocaine.

D M Wood, M W Emmett-Oglesby.   

Abstract

Rats were trained to discriminate cocaine, 10.0 mg/kg, in a two-lever operant procedure. Dose-effect data for generalization to cocaine and substitution of apomorphine for the cocaine stimulus were determined. Subsequently, training was halted and either apomorphine, 2.5 mg/kg per 8 h, or cocaine, 20 mg/kg per 8 h, was administered for 7-9 days. During chronic administration, the efficacy of cocaine and apomorphine as discriminative stimuli was decreased. These data suggest that dopaminergic mechanisms may mediate tolerance to the discriminative stimulus properties of cocaine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3622606     DOI: 10.1016/0014-2999(87)90354-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Differential modulation of cocaine's discriminative cue by repeated and variable stress exposure: relation to monoamine transporter levels.

Authors:  Stephen J Kohut; Kathleen L Decicco-Skinner; Shirin Johari; Zachary E Hurwitz; Michael H Baumann; Anthony L Riley
Journal:  Neuropharmacology       Date:  2012-03-23       Impact factor: 5.250

2.  Tolerance to morphine stimulus control: role of morphine maintenance dose.

Authors:  A M Young; C A Sannerud; E S Steigerwald; M D Doty; W J Lipinski; L E Tetrick
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1984-1987.

Authors:  I P Stolerman; F Rasul; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Effects of the dopamine/norepinephrine releaser phenmetrazine on cocaine self-administration and cocaine-primed reinstatement in rats.

Authors:  Paul W Czoty; Phuong Tran; Leanne N Thomas; Thomas J Martin; Amanda Grigg; Bruce E Blough; Thomas J R Beveridge
Journal:  Psychopharmacology (Berl)       Date:  2015-02-13       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.